Data from MHRA (Medicines and Healthcare products Regulatory Agency, UK) - Curated by EPG Health - Last updated 13 July 2018

Indication(s)

- ZORAC 0.05%, gel
- ZORAC 0.1%, gel


For the topical treatment of mild to moderate plaque psoriasis involving up to 10% body surface area.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Psoriasis

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

Atopic Dermatitis

Atopic Dermatitis

The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

+ 7 more

Load more

Related Content

More information

Category Value
Authorisation number ZORAC 0.05%, gel: PL 41443/0003 - ZORAC 0.1%, gel: PL 41443/0002
Orphan designation No
Date First Approved 30-07-1997
Type Prescription only medicine
Marketing authorisation holder Allergan Pharmaceuticals Ireland